Seneca Biopharma, Inc.
SNCA
|
$1.66
0%
|
Health Technology
(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-79.38% volume)
Earnings Calendar:
Market Cap:
http://www.neuralstem.com
Sec Filling | Patents | 5 employees
Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.
stem cell t-cell nervous system msa ceiling
add to watch list email alert is off
Sierra Oncology, Inc.
SRRA
|
$54.99
0.04%
0.0%
|
Health Technology
(0.0% 1d) (0.0% 1m) (73.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (45.1% volume)
Earnings Calendar: 2022-08-04
Market Cap: $ 1,342,820,002
http://www.sierraoncology.com
Sec Filling | Patents | 71 employees
(CA) Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focuses on advancing targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded on May 8, 2003 and is headquartered in Vancouver, Canada.
cancer treatment profitable
add to watch list email alert is off
Sinovac Biotech, Ltd.
SVA
|
$6.47
0%
|
Health Technology
(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (NaN% volume)
Earnings Calendar:
Market Cap:
http://www.sinovacbio.com
Sec Filling | Patents | 910 employees
(China (Mainland)) Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.
vaccine china infectious disease hepatitis influenza
add to watch list email alert is off
Soliton, Inc.
SOLY
|
$22.58
0%
|
Health Technology
(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-62.06% volume)
Earnings Calendar:
Market Cap:
http://www.soliton.com
Sec Filling | Patents | 10 employees
Soliton, Inc. is a medical development company. It develops healthcare technological devices for medical and cosmetic treatments. The firm’s devices generate planar acoustic waves or shock waves in cosmetic surgical procedures, aesthetic surgical procedures, and dermatology procedures for treatments. The company was founded by Walter V. Klemp & Christopher Capelli on March 27, 2012 and is headquartered in Houston, TX.
aesthetic treatment
add to watch list email alert is off
Spinal Elements Holdings, Inc.
SPEL
|
$
0%
|
Health Technology
(0% volume)
Earnings Calendar:
Market Cap:
Sec Filling | Patents | n/a employees
Spinal Elements Holdings, Inc. is a medical device company. It engages in designing, developing, manufacturing, and marketing of innovative medical devices used in spinal surgical procedures. The company was founded on March 11, 2016 and is headquartered in Carlsbad, CA.
add to watch list email alert is off
Spring Bank Pharmaceuticals, Inc.
SBPH
|
$
0%
|
Health Technology
(0% volume)
Earnings Calendar:
Market Cap:
http://www.springbankpharm.com
Sec Filling | Patents | 30 employees
Spring Bank Pharmaceuticals, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA.
cancer glass treatment injection
add to watch list email alert is off
Stealth BioTherapeutics Corp.
MITO
|
$0.32
0.25%
|
Health Technology
(0.0% 1d) (0.0% 1m) (-50.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1824.23% volume)
Earnings Calendar:
Market Cap: $ 23,536,789
http://www.stealthbt.com
Sec Filling | Patents | 73 employees
(KY) Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. The company was founded on April 3, 2006 and is headquartered in Newton, MA.
mitochondrial dysfunction parkinson sbt-272 tdp-43
add to watch list email alert is off
Sun BioPharma, Inc.
SNBP
|
$3.44
0%
|
Health Technology
(0.0% 1m) (0.0% 1y) (0.0% 7d) (161.81% volume)
Earnings Calendar:
Market Cap:
http://www.sunbiopharma.com
Sec Filling | Patents | 5 employees
Sun BioPharma Inc. engages in the development of disruptive therapeutics for medical purposes. It focuses on development programs that target diseases of the pancreas, including pancreatic cancer and pancreatitis. The company was founded by Michael Cullen and Thomas Neenan on September 21, 2011 and is headquartered in Waconia, MN.
cancer pancreatic
add to watch list email alert is off
Sunesis Pharmaceuticals, Inc.
SNSS
|
$13.5
0%
|
Health Technology
(0.0% 1m) (0.0% 1y) (0.0% 2d) (153.8% 3d) (0.0% 7d) (-99.11% volume)
Earnings Calendar:
Market Cap:
http://www.sunesis.com
Sec Filling | Patents | 24 employees
Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA.
cancer clinical trials treatment
add to watch list email alert is off
Taiwan Liposome Company, Ltd.
TLC
|
$7.0
0%
|
Health Technology
(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-69.07% volume)
Earnings Calendar:
Market Cap:
http://www.tlcbio.com
Sec Filling | Patents | n/a employees
Taiwan Liposome Co., Ltd. engages in the authorized cooperative development of special medicine as well as new formulation and prescription drugs. The firm offers pain management, ophthalmology, and oncology related drugs based on lipid drug delivery system. It also provides royalties and biotechnology services. The company was founded by Chi Lung Hung on November 10, 1997 and is headquartered in Taipei, Taiwan.
royalties lungs drug delivery
add to watch list email alert is off
Teligent, Inc.
TLGT
|
$0.1735
0%
|
Health Technology
(0.0% 1d) (-13.9% 1m) (0.0% 1y) (-13.9% 2d) (-47.9% 3d) (0.0% 7d) (-26.89% volume)
Earnings Calendar:
Market Cap:
http://www.teligent.com
Sec Filling | Patents | 252 employees
Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. It also provides contract manufacturing services to the pharmaceutical, over-the-counter, and cosmetic markets. The company was founded by Jane E. Hager in 1977 and is headquartered in Buena, NJ.
brands injection
Drugs
Lidocaine 4% Cream (Lidocaine)ZANTAC (ranitidine hydrochloride)
add to watch list email alert is off
Tricida, Inc.
TCDA
|
$0.108
-22.22%
0
|
Health Technology
(0.0% 1d) (-39.9% 1m) (-99.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-44.76% volume)
Earnings Calendar: 2023-02-22
Market Cap: $ 6,012,239
http://www.tricida.com
Sec Filling | Patents | 119 employees
(US) Tricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker in 2013 and is headquartered in South San Francisco, CA.
kidney diseases metabolic kidney
add to watch list email alert is off
Turning Point Therapeutics, Inc.
TPTX
|
$76.01
-0.03%
|
Health Technology
(0.0% 1d) (0.0% 1m) (112.6% 1y) (0.0% 2d) (0.0% 3d) (0.7% 7d) (NaN% volume)
Earnings Calendar: 2022-11-08
Market Cap: $ 3,806,145,795
http://www.tptherapeutics.com
Sec Filling | Patents | 95 employees
Turning Point Therapeutics, Inc. engages in the discovery and development of precision medicines for cancer and other diseases. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by J. Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA.
cancer
add to watch list email alert is off
Tyme Technologies, Inc.
TYME
|
$0.3107
-8.21%
|
Health Technology
(0.0% 1d) (0.0% 1m) (-11.8% 1y) (8.1% 2d) (18.4% 3d) (0.0% 7d) (-9.91% volume)
Earnings Calendar:
Market Cap: $ 53,504,682
http://www.tymeinc.com
Sec Filling | Patents | 18 employees
(United States) Tyme Technologies, Inc. is a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ.
cancer t-cell ceiling
add to watch list email alert is off
Urovant Sciences Ltd.
UROV
|
$16.24
0%
|
Health Technology
(0.1% 1m) (0.0% 1y) (0.0% 2d) (0.1% 3d) (0.0% 7d) (1161.77% volume)
Earnings Calendar:
Market Cap:
http://www.urovant.com
Sec Filling | Patents | n/a employees
Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom.
add to watch list email alert is off
Pandion Therapeutics Inc.
PAND
|
$60.05
0%
|
Health Technology
(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-13.33% volume)
Earnings Calendar:
Market Cap:
http://www.pandiontx.com
Sec Filling | Patents | 37 employees
Pandion Therapeutics, Inc. is clinical stage biopharmaceutical company developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases. The firm develops Therapeutic Autoimmune reguLatOry protein (TALON) drug design and discovery platform. TALON platform employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network. The company was founded on December 31, 2018 and is headquartered in Watertown, MA.
autoimmunity
add to watch list email alert is off
PDL BioPharma, Inc.
PDLI
|
$2.47
0%
|
Health Technology
(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap:
http://www.pdl.com
Sec Filling | Patents | 75 employees
PDL BioPharma, Inc. produces and markets biopharmaceutical products. It operates through the following segments: Income Generating Assets, Pharmaceutical, and Medical Devices. The Income Generating Assets segment consists of revenues derived from notes and other long-term receivables, royalty rights-at fair value, equity investments, and royalties from issued patents in the United States and elsewhere. The Pharmaceutical segment covers revenues from branded prescription medicine products being sold under the name Tekturna and Tekturna HCT in the United States, and Rasilez and Rasilez HCT for the rest of the world. The Medical Devices segment handles revenues from the LENSAR Laser System sales. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Incline Village, NV.
royalties brands
add to watch list email alert is off
Proteostasis Therapeutics, Inc.
PTI
|
$1.11
0%
|
Health Technology
(0.0% 1m) (0.0% 1y) (0.0% 3d) (0.0% 7d) (149.87% volume)
Earnings Calendar:
Market Cap:
http://www.proteostasis.com
Sec Filling | Patents | 44 employees
Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA.
fibrosis msa
add to watch list email alert is off
Retrophin, Inc.
RTRX
|
$
0%
|
Health Technology
(0% volume)
Earnings Calendar:
Market Cap:
http://www.retrophin.com
Sec Filling | Patents | 221 employees
(US) Retrophin, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.
Drugs
Chenodal (Chenodiol)add to watch list email alert is off
XTL Biopharmaceuticals Ltd.
XTLB
|
$1.3499
-2.96%
16
|
Health Technology
(0.0% 1d) (-2.2% 1m) (-43.4% 1y) (0.0% 2d) (8.9% 3d) (0.0% 7d) (-46.58% volume)
Earnings Calendar:
Market Cap: $ 7,355,689
http://www.xtlbio.com
Sec Filling | Patents | 4 employees
XTL Biopharmaceuticals Ltd. focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company was founded on March 9, 1993 and is headquartered in Raanana, Israel.
acquisitions israel treatment
add to watch list email alert is off
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 57% | 43% |
Top 10 Gainers
CZOO | $0.2001 -16.63% 1819.04% 10K
|
AVRO | News | $1.69 93.7% 50.71% 850K
|
Health Technology
WLDS | News | $0.6295 -2.05% 45.53% 11M
|
HPCO | $0.755 -6.05% 34.67% 3.7M
|
KPRX | $6.94 52.53% 27.66% 230K
|
Manufacturing
ICU | $4.8 3.67% 21.26% 740K
|
SOUN 4 | $4.63 28.61% 21.05% 3M
|
MSGM P 2 d | $16.07 21.93% 13.23% 23K
|
RAAS | $0.8897 0.62% 12.39% 410K
|
Information
SASI 4 | $0.6615 -2.72% 11.87% 10K
|
Manufacturing
Last 48 Hours Insiders Buying
PMT P 10340 | $14.42 0.35% 1.18% 1.3K
|
Finance
|
01:30
APPN P 50000 | $42.79 -1.45% -1.47% 230
|
Technology Services
|
23:30
BOKF P 1000 | $103.18 -1.45% -1.37% 110K
|
Finance
|
23:00
IVAC P 15000 | $7.08 1.87% 1.7% 6
|
Electronic Technology
|
22:30
FKYS P 599 | $21.75 0.37% 0
|
Finance and Insurance
|
22:20
ASRV P 1884 | $4.015 0.38% 0.74% 4.2K
|
Finance
|
19:40
RILY P 20000 | $39.6 -10.2% -13.05% 2.8K
|
Finance
|
19:40
BSGM P 349323 | $1.17 2.63% 2.56% 43K
|
Health Technology
|
17:30
HPKEW 4 | $16.0 0%
|
Industrial Services
|
23:50